Cancer-Channel Icon 

The heterogeneity and complexity of malignant tumors has changed the way we think about the initiation, progression, diagnosis, and management of cancer. The Cancer Channel will explore the emerging molecular markers, improved preclinical models, genomic-based and immune-modulated therapies that are enabling precision oncology.

Cancer Molecular Markers

Circulating Tumor Cells

Cancer Immunotherapy - New

Predictive Preclinical Models in Oncology


You may also be interested in:


Circulating Cell-Free DNA

Biomarkers for Cancer Immunotherapy


Premier Sponsors:  

Bina Technologies




Jackson Laboratory - small logo 


 Precision for Medicine 


Silicon Biosystems

Thomson Reuters-Large